Around the world, medical professionals and researchers are finding innovative ways to fight the SARS Cov-2 virus, while in tandem, businesses are transforming their operations to overcome obstacles presented by the pandemic. 

Hear from cutting-edge speakers representing both French and American perspectives on innovation and collaboration. Understand the real-world applications of new and evolving technologies and how tech is transforming every aspect of the healthcare and the pharmaceutical industries. Get an inside perspective into how doctors and scientists are transforming their relationship with raw data, pairing human intelligence with advanced machine learning to build the future of health.

REGISTER NOW

Thomas Clozel, M.D., Co-Founder & CEO of OWKIN, a French-American startup that provides machine learning which allows medical researchers to test AI models on distributed data. Owkin is introducing the COVID-19 Open AI Consortium (COAI) to bring breakthrough medical discoveries and actionable findings to the fight against the COVID-19 pandemic.

Philippe Krolicki, Co-Founder & COO of OptiChroniX, a digital therapeutics startup aiming to optimize brain health by improving lifestyle, optimizing treatment plans, providing active follow up and improving healthcare resource utilization. Philippe is also the Founder of p-Valorem, a life sciences consulting firm, and hold a Bachelor’s in Science in Pharmacy and a Master’s Degree in Pharmaceutical Marketing & Management from Paris V – Université René Descartes.

Dr. David Luu, M.D., is a cardiac surgeon, healthcare entrepreneur, and philanthropist. He is the Founder & CEO of Absolutys, a venture studio aimed towards building health companies that impact lives globally. He is also the Founder & CEO of The Heart Fund, a United Nations ECOSOC accredited NGO delivering cardiovascular care in developing countries.